We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$484B
AUM Growth
+$13.2B
Cap. Flow
-$3.88B
Cap. Flow %
-0.8%
Top 10 Hldgs %
13.39%
Holding
2,630
New
93
Increased
1,078
Reduced
887
Closed
93

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.6B
2
BNY
Bank of New York Mellon
BNY
+$1.1B
3
ELV icon
Elevance Health
ELV
+$903M
4
DD
Du Pont De Nemours E I
DD
+$873M
5
MDT icon
Medtronic
MDT
+$868M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$3.89B
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.06B
3
CFN
CAREFUSION CORPORATION
CFN
+$946M
4
APTV icon
Aptiv
APTV
+$886M
5
KSU
Kansas City Southern
KSU
+$662M

Sector Composition

Rank Sector Weight
1 Healthcare 21.05%
2 Consumer Discretionary 13.82%
3 Financials 13.14%
4 Industrials 11.9%
5 Technology 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECD
1676
DELISTED
Tech Data Corp
TECD
$1.19M ﹤0.01%
20,580
– –
NOG icon
1677
Northern Oil and Gas
NOG
$2.61B
$1.18M ﹤0.01%
15,360
-287,631
-95% -$20.8M
SITC icon
1678
SITE Centers
SITC
$158M
$1.18M ﹤0.01%
49,360
– –
CHK.PRD
1679
DELISTED
Chesapeake Energy Corp. 4.5% Cum. Cnvrtbl. Prfrd. Stock
CHK.PRD
$1.18M ﹤0.01%
13,443
-1,140
-8% -$102K
WCC
1680
WESCO International
WCC
$17.5B
$1.17M ﹤0.01%
16,751
+4,000
+31% +$277K
NJR icon
1681
New Jersey Resources
NJR
$5.64B
$1.17M ﹤0.01%
37,550
-3,200
-8% -$100K
EGN
1682
DELISTED
Energen
EGN
$1.16M ﹤0.01%
17,571
+253
+1% +$16.3K
ALSN icon
1683
Allison Transmission
ALSN
$10.2B
$1.15M ﹤0.01%
36,000
+3,300
+10% +$106K
TUP
1684
DELISTED
Tupperware Brands Corporation
TUP
$1.15M ﹤0.01%
16,620
-1,500
-8% -$101K
GPOR
1685
DELISTED
Gulfport Energy Corp.
GPOR
$1.15M ﹤0.01%
24,952
-1,281
-5% -$54.2K
JD icon
1686
JD.com
JD
$39.6B
$1.15M ﹤0.01%
38,973
-126,907
-77% -$3.41M
CST
1687
DELISTED
CST Brands, Inc.
CST
$1.14M ﹤0.01%
26,111
+7,500
+40% +$326K
CRL icon
1688
Charles River Laboratories
CRL
$13.4B
$1.14M ﹤0.01%
14,401
+74
+0.5% +$5.46K
GIMO
1689
DELISTED
Gigamon Inc.
GIMO
$1.14M ﹤0.01%
+53,414
New +$1.03M
GTE icon
1690
Gran Tierra Energy
GTE
$336M
$1.11M ﹤0.01%
40,806
-3,930
-9% -$106K
THO icon
1691
Thor Industries
THO
$4.11B
$1.11M ﹤0.01%
17,500
-2,300
-12% -$137K
CIM
1692
Chimera Investment
CIM
$993M
$1.1M ﹤0.01%
23,460
– –
DBD
1693
DELISTED
Diebold Nixdorf Incorporated
DBD
$1.1M ﹤0.01%
30,990
– –
AXLL
1694
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$1.1M ﹤0.01%
23,400
+3,300
+16% +$149K
BMR
1695
DELISTED
BIOMED REALTY TRUST INC
BMR
$1.1M ﹤0.01%
48,400
– –
FCRD
1696
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$1.09M ﹤0.01%
89,100
-543,020
-86% -$6.36M
ITT icon
1697
ITT
ITT
$19.4B
$1.09M ﹤0.01%
27,400
– –
IMI
1698
DELISTED
Intermolecular, Inc.
IMI
$1.09M ﹤0.01%
663,000
– –
PNK
1699
DELISTED
Pinnacle Entertainment Inc.
PNK
$1.08M ﹤0.01%
30,000
+5,900
+24% +$158K
CRI icon
1700
Carter's
CRI
$1.44B
$1.08M ﹤0.01%
11,700
– –
66 67
68
69 70

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q1 2015 Portfolio in Review

As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
  • T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
  • T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
  • T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
  • T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.